Overview
?
DAVID BURTON
See more contacts
Scientific Research and Development Services
,
Medical Equipment and Supplies Manufacturing
,
Other Electrical Equipment and Component Manufacturing
,
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
,
Professional and Commercial Equipment and Supplies Merchant Wholesalers
See All Industries , Commercial physical research , Surgical and medical instruments , Electrical equipment and supplies, nec , Electromedical equipment , Medical and hospital equipment Holding companies, nec
See Fewer Industries
See All Industries , Commercial physical research , Surgical and medical instruments , Electrical equipment and supplies, nec , Electromedical equipment , Medical and hospital equipment Holding companies, nec
See Fewer Industries
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
Estimated
$32.91 million
Actual
17.24%
$40
JUN
?
?
Australian:CMP
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of June 30, 2024 (12 month period) in USD
Annual Revenue 2024
$32.91 million
USD
Actual
1 USD = 1.5109 AUD
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $ | $ | $ |
| Net Investing Cash | -$3 | -$3 | -$2 |
| Net Financing Cash | -$1 | -$1 | $1 |
| Net Change in Cash | -$2 | -$4 | $1 |
| Cash at Beginning of Period | $2 | $5 | $3 |
| Cash at End of Period | -$0 | $2 | $5 |
| Capital Expenditure | -$3 | -$3 | -$2 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $1 | $3 | $5 |
| Accounts Receivable | $7 | $8 | $9 |
| Inventories | $9 | $7 | $6 |
| Other Current Assets | $0 | $2 | $2 |
| Asset Summary | |||
| Total Current Assets | $17 | $20 | $22 |
| Tangible Fixed Assets | $2 | $2 | $1 |
| Intangible Assets | $7 | $4 | $4 |
| Total Assets | $40 | $41 | $41 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $5 | $4 | $4 |
| Short-Term Debt | $5 | $5 | $4 |
| Other Current Liabilities | $4 | $5 | $4 |
| Liability Summary | |||
| Total Current Liabilities | $14 | $14 | $11 |
| Long-Term Debt | $ | $0 | $0 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $15 | $15 | $12 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $24 | $24 | $24 |
| Retained Earnings | -$12 | -$12 | -$8 |
| Equity Summary | |||
| Total Equity | $12 | $12 | $16 |
| Shares Outstanding | 177,162,948 | 177,162,948 | 177,162,948 |